Page 4 - Fei Shen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fei shen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fei Shen Today - Breaking & Trending Today

Panel Discussion: –Raising a Series A Round" ⋆ Princeton, NJ local news

Panel Discussion: –Raising a Series A Round" ⋆ Princeton, NJ local news
planetprinceton.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from planetprinceton.com Daily Mail and Mail on Sunday newspapers.

Kristina Fontanez , Tony Williams , Mark Esposito , Fei Shen , Office Of Technology Licensing , Princeton Entrepreneurship Council , Princeton University , Fluent Biosciences Inc , Princeton Innovation Center Biolabs , Boehringer Ingelheim Venture Fund United States Inc , Fluent Biosciences , Boehringer Ingelheim Venture Fund United States , Technology Licensing , Princeton Entrepreneurship ,

Panel Discussion: Raising a Series A Round

Raising a Series A round is a major milestone for a high-growth startup. To get there, you need to convince investors that you have a viable business model with strong growth potential.
Join Princeton Entrepreneurship Council and Princeton Innovation Center Biolabs on Tuesday, March 29, from 12–1:30 p.m. EDT via Zoom. Our panel of experts will discuss what it takes to raise a successful Series A round, including how to know when it’s time to raise your first round, implications of raising capital, how long the process takes, and much more.
Panelists:

Mark Esposito 17, KayoThera

Kristina Fontanez '05, Fluent BioSciences

Fei Shen, Boehringer Ingelheim Ventures

Anthony Williams, Office of Technology Licensing, Princeton University ....

Kristina Fontanez , Anthony Williams , Mark Esposito , Fei Shen , Office Of Technology Licensing , Princeton Entrepreneurship Council , Princeton University , Princeton Innovation Center Biolabs , Boehringer Ingelheim , Technology Licensing ,

ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance

ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance - read this article along with other careers information, tips and advice on BioSpace ....

United States , Lloyd Payne , Viva Bioinnovator , Fei Shen , Zemer Gitai , Impact Fund Scientific Selection Board , Action Fund Scientific Advisory Board , Boehringer Ingelheim Venture Fund United States , World Health Organization , Princeton University , Us Centers For Disease , Boehringer Ingelheim Venture Fund , Insight Partners , Innospark Ventures , Arimed Capital , Arrepath President , Business Wire , Fund Scientific Selection Board , Fund Scientific Advisory Board , Executive Vice President , Artificial Intelligence , Machine Learning Based , Managing Director , Boehringer Ingelheim Venture Fund United , Edwin Grant Conklin Professor , Disease Control ,

ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance

PRINCETON, N.J. (BUSINESS WIRE) Mar 3, 2022 ....

United States , Lloyd Payne , Robert Gottlieb , Viva Bioinnovator , Fei Shen , Zemer Gitai , Impact Fund Scientific Selection Board , Action Fund Scientific Advisory Board , Boehringer Ingelheim Venture Fund United States , World Health Organization , Princeton University , Us Centers For Disease , Boehringer Ingelheim Venture Fund , Insight Partners , Innospark Ventures , Arimed Capital , Arrepath President , Business Wire , Fund Scientific Selection Board , Fund Scientific Advisory Board , Executive Vice President , Artificial Intelligence , Machine Learning Based , Managing Director , Boehringer Ingelheim Venture Fund United , Edwin Grant Conklin Professor ,